Markers of neutrophil activation and neutrophil extracellular traps in diagnosing patients with acute venous thromboembolism: A feasibility study based on two VTE cohorts.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
01
10
2021
accepted:
19
06
2022
entrez:
28
7
2022
pubmed:
29
7
2022
medline:
2
8
2022
Statut:
epublish
Résumé
Venous thromboembolism (VTE) diagnosis would greatly benefit from the identification of novel biomarkers to complement D-dimer, a marker limited by low specificity. Neutrophil extracellular traps (NETs) have been shown to promote thrombosis and could hypothetically be used for diagnosis of acute VTE. To assess the levels of specific markers of neutrophil activation and NETs and compare their diagnostic accuracy to D-dimer. We measured plasma levels of neutrophil activation marker neutrophil elastase (NE), the NET marker nucleosomal citrullinated histone H3 (H3Cit-DNA) and cell-free DNA in patients (n = 294) with suspected VTE (pulmonary embolism and deep vein thrombosis) as well as healthy controls (n = 30). A total of 112 VTE positive and 182 VTE negative patients from two prospective cohort studies were included. Higher levels of H3Cit-DNA and NE, but not cell-free DNA, were associated with VTE. Area under receiver operating curves (AUC) were 0.90 and 0.93 for D-dimer, 0.65 and 0.68 for NE and 0.60 and 0.67 for H3Cit-DNA in the respective cohorts. Adding NE and H3Cit-DNA to a D-dimer based risk model did not improve AUC. Our study demonstrates the presence of neutrophil activation and NET formation in VTE using specific markers. However, the addition of NE or H3Cit-DNA to D-dimer did not improve the discrimination compared to D-dimer alone. This study provides information on the feasibility of using markers of NETs as diagnostic tools in acute VTE. Based on our findings, we believe the potential of these markers are limited in this setting.
Sections du résumé
BACKGROUND
Venous thromboembolism (VTE) diagnosis would greatly benefit from the identification of novel biomarkers to complement D-dimer, a marker limited by low specificity. Neutrophil extracellular traps (NETs) have been shown to promote thrombosis and could hypothetically be used for diagnosis of acute VTE.
OBJECTIVES
To assess the levels of specific markers of neutrophil activation and NETs and compare their diagnostic accuracy to D-dimer.
METHODS
We measured plasma levels of neutrophil activation marker neutrophil elastase (NE), the NET marker nucleosomal citrullinated histone H3 (H3Cit-DNA) and cell-free DNA in patients (n = 294) with suspected VTE (pulmonary embolism and deep vein thrombosis) as well as healthy controls (n = 30). A total of 112 VTE positive and 182 VTE negative patients from two prospective cohort studies were included.
RESULTS
Higher levels of H3Cit-DNA and NE, but not cell-free DNA, were associated with VTE. Area under receiver operating curves (AUC) were 0.90 and 0.93 for D-dimer, 0.65 and 0.68 for NE and 0.60 and 0.67 for H3Cit-DNA in the respective cohorts. Adding NE and H3Cit-DNA to a D-dimer based risk model did not improve AUC.
CONCLUSIONS
Our study demonstrates the presence of neutrophil activation and NET formation in VTE using specific markers. However, the addition of NE or H3Cit-DNA to D-dimer did not improve the discrimination compared to D-dimer alone. This study provides information on the feasibility of using markers of NETs as diagnostic tools in acute VTE. Based on our findings, we believe the potential of these markers are limited in this setting.
Identifiants
pubmed: 35901107
doi: 10.1371/journal.pone.0270865
pii: PONE-D-21-31635
pmc: PMC9333265
doi:
Substances chimiques
Biomarkers
0
Fibrin Fibrinogen Degradation Products
0
Histones
0
DNA
9007-49-2
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0270865Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Clin Cancer Res. 2016 Aug 1;22(15):3924-36
pubmed: 26957562
J Vasc Surg Venous Lymphat Disord. 2016 Oct;4(4):508-17
pubmed: 27639008
J Thromb Haemost. 2020 Oct;18(10):2732-2743
pubmed: 32654410
PLoS One. 2018 Jan 11;13(1):e0191231
pubmed: 29324871
Science. 2004 Mar 5;303(5663):1532-5
pubmed: 15001782
Proc Natl Acad Sci U S A. 2012 Aug 7;109(32):13076-81
pubmed: 22826226
J Thromb Haemost. 2018 May;16(5):866-875
pubmed: 29505695
Thromb Haemost. 2017 Oct 5;117(10):1919-1929
pubmed: 28837206
BMJ. 1989 Oct 14;299(6705):951-2
pubmed: 2508949
Front Immunol. 2016 Jun 27;7:236
pubmed: 27446071
Blood. 2015 Jul 9;126(2):242-6
pubmed: 25979951
South Med J. 1980 Mar;73(3):345-6, 350
pubmed: 7361141
Blood. 2016 Dec 8;128(23):e59-e66
pubmed: 27742707
N Engl J Med. 2003 Sep 25;349(13):1227-35
pubmed: 14507948
Arterioscler Thromb Vasc Biol. 2013 Jan;33(1):147-51
pubmed: 23104849
Clin Appl Thromb Hemost. 2011 Aug;17(4):425-31
pubmed: 21593019
Acad Emerg Med. 2008 Sep;15(9):795-9
pubmed: 19244629
Ann Intern Med. 2001 Jul 17;135(2):98-107
pubmed: 11453709
Intensive Care Med Exp. 2019 May 22;7(1):29
pubmed: 31119471
Science. 2017 Dec 1;358(6367):1202-1206
pubmed: 29191910
J Thromb Haemost. 2021 May;19(5):1271-1282
pubmed: 33638267
J Vasc Surg Venous Lymphat Disord. 2013 Oct 1;1(4):
pubmed: 24187669
Eur Heart J. 2020 Jan 21;41(4):543-603
pubmed: 31504429
J Thromb Haemost. 2019 May;17(5):818-826
pubmed: 30803124
J Thromb Haemost. 2014 Jun;12(6):860-70
pubmed: 24674135
Intern Med J. 2007 Sep;37(9):607-13
pubmed: 17543005
Chest. 1990 Jan;97(1):63-8
pubmed: 2295262
Thromb Res. 2020 Jan;185:119-124
pubmed: 31805421
J Vasc Surg Venous Lymphat Disord. 2015 Oct;3(4):347-353.e1
pubmed: 26992609
Ann Intern Med. 2006 Feb 7;144(3):165-71
pubmed: 16461960
Front Immunol. 2012 Oct 04;3:307
pubmed: 23060885
Intern Med J. 2017 Oct;47(10):1154-1160
pubmed: 28635149
Q J Med. 1992 May;83(301):369-79
pubmed: 1438672
Respiration. 1984;45(1):45-9
pubmed: 6689797
BMJ. 2010 Mar 30;340:c1475
pubmed: 20354012
Am Rev Respir Dis. 1978 Sep;118(3):475-8
pubmed: 707876
Am Rev Respir Dis. 1982 Apr;125(4):416-9
pubmed: 7073111
Thorax. 1983 Mar;38(3):209-11
pubmed: 6857586
J Thromb Haemost. 2004 Aug;2(8):1247-55
pubmed: 15304025
Arterioscler Thromb Vasc Biol. 2019 Sep;39(9):1724-1738
pubmed: 31315434
Am Rev Respir Dis. 1982 Aug;126(2):360-1
pubmed: 7103265
Thromb Haemost. 2013 Feb;109(2):290-7
pubmed: 23238559
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15880-5
pubmed: 20798043
Acad Emerg Med. 2010 Jun;17(6):589-97
pubmed: 20624138
J Thromb Thrombolysis. 2016 Jan;41(1):3-14
pubmed: 26780736
Semin Thromb Hemost. 2019 Feb;45(1):86-93
pubmed: 30634198